a systematic review on incidence, risk factors, and prognosis, including a meta-analysis of risk-modifying drugs
The aim of this review is to focus on risk factors, risk-modifying drugs and prognosis for upper limb arterial thromboembolism, and the relationship between upper limb arterial thromboembolism and atrial fibrillation (AF).
Journal review article
Journal of Thrombosis and Haemostasis, 2013, Vol 11, Issue 5, p. 836-44
Anticoagulants; Arm; Arteries; Clinical Trials, Phase III as Topic; Humans; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Thrombectomy; Thromboembolism